Simultaneous echocardiography and myocardial perfusion single photon emission computed tomography associated with dobutamine stress to predict long-term cardiac mortality in normotensive and hypertensive patients

Journal of Hypertension

Volumn 23, Issue 7, 2005, Pages 1409-1415

  Bigi, Riccardo ^a,b   Bax, Jeroen J ^c   Van Domburg, Ron T ^d   Elhendy, Abdou ^e   Cortigiani, Lauro ^f   Schinkel, Arend F L ^c   Fiorentini, Cesare ^a   Poldermans, Don ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e NEBRASKA MEDICAL CENTER   (United States)

^f CAMPO DI MARTE HOSPITAL   (Italy)

Author keywords

Dobutamine; Hypertension; Risk assessment; SPECT; Stress echocardiography

Indexed keywords

DOBUTAMINE;

AGED; ARTICLE; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; EXERCISE ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART MUSCLE PERFUSION; HUMAN; HYPERTENSION; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTOLIC BLOOD PRESSURE;

EID: 21644458878     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000173525.88426.30     Document Type: Article

References (29)

1. WHO Expert Committee. Hypertension control. WHO Technical Report Series 862. Geneva: World Health Organization; 1997.
2. Frohlich ED, Apstein C, Chobanian AV, Devereux RB, Dustan HP, Dzau V, et al. The heart in hypertension. N Engl J Med 1992; 327:998-1008.
3. Wroblewski EM, Pearl FJ, Hammer WJ, Bove AA. False positive stress tests due to undetected left ventricular hypertrophy. Am J Epidemiol 1982; 115:412-417.
4. Cheitlin MD, Alpert JS, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, et al. ACC/AHA guidelines for the clinical application of echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committe on Clinical Application of Echocardiography), developed in collaboration with the American Society of Echocardiography. Circulation 1997; 95:1686-1744.
5. Cortigiani L, Paolini EA, Nannini E. Dipyridamole stress echocardiography for risk stratification in hypertensive patients with chest pain. Circulation 1998; 98:2855-2859.
6. Cortigiani L, Coletta C, Bigi R, Amici E, Desideri A, Odoguardi L. Clinical, exercise electrocardiographic, and pharmacologic stress echocardiographic findings for risk stratification of hypertensive patients with chest pain. Am J Cardiol 2003; 91:941-945.
7. Marwick TH, Case C, Sawada S, Vasey C, Thomas JD. Prediction of outcomes in hypertensive patients with suspected coronary disease. Hypertension 2002; 39:1113-1118.
8. Geleijnse ML, Elhendy A, van Domburg RT, Cornel JH, Rambaldi R, Salustri A, et al. Cardiac imaging for risk stratification with dobutamine-atropine stress testing in patients with chest pain. Echocardiography, perfusion scintigraphy, or both? Circulation 1997; 96:137-147.
9. 201TI, ECG, and clinical variables in patients evaluated for coronary artery disease. Circulation 1998; 98:2679-2686.
10. Fragasso G, Lu C, Dabrowski P, Pagnotta P, Sheiban I, Chierchia SL. Comparison of stress/rest myocardial perfusion tomography, dipyridamole and dobutamine stress echocardiography for the detection of coronary disease in hypertensive patients with chest pain and positive exercise test. J Am Coll Cardiol 1999; 34:441-447.
11. Astarita C, Palinkas A, Nicolai E, Maresca FS, Varga A, Picano E. Dipyridamole-atropine stress echocardiography versus exercise SPECT scintigraphy for detection of coronary artery disease in hypertensives with positive exercise test. J Hypertens 2001; 19:495-502.
12. Elhendy A, Geleijnse ML, van Domburg RT, Bax JJ, Nierop PR, Beerens SAM, et al. Comparison of dobutamine stress echocardiography and technetium-99m sestamibi single-photon emission tomography for the diagnosis of coronary artery disease in hypertensive patients with and without left ventricular hypertrophy. Eur J Nucl Med 1998; 25:69-78.
13. The sixth report on the Joint National Committee on the detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 24:2413-2446.
14. World Health Organization. Diabetes mellitus. Report of a WHO study group. Technical Report Series number 727. Geneva: World Health Organization; 1985.
15. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335:1001-1009.
16. Braunwald E (chair). Report of the task force on research in heart failure. Bethesda, MD: National Heart, Lung and Blood Institute; 1994.
17. Poldermans D, Fioretti PM, Boersma E, Bax JJ, Thomson IR, Roelandt JRTC, Simoons ML. Long-term prognostic value of dobutamine-atropine stress echocardiography in 1737 patients with known or suspected coronary artery disease: a single-center experience. Circulation 1999; 99:757-762.
18. Iskandrian AS, Heo J, Kong B, Lyons E. Effect of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery disease: analysis of 461 patients. J Am Coll Cardiol 1989; 14:1477-1486.
19. Elhendy A, Bax JJ, Poldermans D. Dobutamine stress myocardial perfusion imaging in coronary artery disease. J Nucl Med 2002; 43:1634-1646.
20. Houghton JL, Frank MJ, Carr AA, von Dohlen TW, Prisant LM. Relations among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease. J Am Coll Cardiol 1990; 15:43-51.
21. Prisant LM, Von Dohlen TW, Houghton JL, Frank MJ. A negative thallium (+/- dipyridamole) stress test excludes significant obstructive epicardial coronary artery disease in hypertensive patients. Am J Hypertens 1992; 5:71-75.
22. Iriarte M, Caso R, Murga N, Faus JM, Sagastagoitia D, Molinero E, et al. Microvascular angina pectoris in hypertensive patients with left-ventricular hypertrophy and diagnostic value of exercise thallium 201 scintigraphy. Am J Cardiol 1995; 75:335-339.
23. Elhendy A, van Domburg RT, Sozzi FB, Poldermans D, Bax JJ, Roelandt JRTC. Impact of hypertension on the accuracy of exercise stress myocardial perfusion imaging for the diagnosis of coronary artery disease. Heart 2001; 85:655-661.
24. Elhendy A, van Domburg RT, Bax JJ, Ibrahim MM, Roelandt JR. Myocardial perfusion abnormalities in treated hypertensive patients without known coronary artery disease. J Hypertens 1999; 17:1601-1606.
25. Amanullah AM, Berman DS, Kang XP, Cohen I, Germano G, Friedman JD. Enhanced prognostic stratification of patients with left ventricular hypertrophy with the use of single-photon emission computed tomography. Am Heart J 2000; 140:456-462.
26. Elhendy A, Schinkel AF, Van Domburg RT, Bax JJ, Poldermans D. Prediction of cardiac death in hypertensive patients with suspected or known coronary artery disease by stress technetium-99m tetrofosmin myocardial perfusion imaging. J Hypertens 2003; 21:1945-1951.
27. Pasquet A, D'Hondt AM, Verhelst R, Vanoverschelde JL, Melin J, Marwick TH. Comparison of dipyridamole stress echocardiography and perfusion scintigraphy for cardiac risk stratification in vascular surgery patients. Am J Cardiol 1998; 82:1468-1474.
28. van Daele ME, McNeill AJ, Fioretti PM, Salustri A, Pozzoli MM, el-Said ES, et al. Prognostic value of dipyridamole sestamibi single-photon emission computed tomography and dipyridamole stress echocardiography for new cardiac events after an uncomplicated myocardial infarction. J Am Soc Echocardiogr 1994; 7:370-380.
29. Bigi R, Cortigiani L, Gregori D, De Chiara B, Parodi O, Fiorentini C. Exercise versus recovery electrocardiography for predicting outcome in hypertensive patients with chest pain. J Hypertens 2004; 22:2193-2199.